10.08.2013 Views

Report in English with a Dutch summary (KCE reports 45A)

Report in English with a Dutch summary (KCE reports 45A)

Report in English with a Dutch summary (KCE reports 45A)

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>KCE</strong> <strong>reports</strong> vol.45 Screen<strong>in</strong>g for Colorectal Cancer: Appendices 181<br />

Nr. Title Issued by Year Familial Adenomatous Polyposis<br />

(FAP) & related<br />

7 Surveillance and<br />

management of groups at<br />

<strong>in</strong>creased risk of<br />

colorectal cancer 27.<br />

New Zealand<br />

Guidel<strong>in</strong>es Group<br />

(NZGG)<br />

2004 1. Offer referral to a genetic<br />

service for consideration of<br />

genetic test<strong>in</strong>g <strong>with</strong><strong>in</strong> the context<br />

of appropriate counsel<strong>in</strong>g to:<br />

Individuals <strong>with</strong> a cl<strong>in</strong>ical<br />

diagnosis of FAP<br />

All at-risk family members if a<br />

family-specific genetic mutation<br />

has been identified at the age<br />

when sigmoidoscopic surveillance<br />

would normally beg<strong>in</strong><br />

2. Sigmoidoscopy 1- to 2-yearly<br />

from the age of 12 to 15 y is<br />

recommended for asymptomatic<br />

<strong>in</strong>dividuals <strong>with</strong> an identified<br />

disease-caus<strong>in</strong>g FAP mutation and<br />

for all at-risk members of families<br />

<strong>with</strong> FAP if genetic test<strong>in</strong>g is not<br />

available or is non<strong>in</strong>formative.<br />

3. Increase the <strong>in</strong>terval for<br />

sigmoidoscopic surveillance to 3yearly<br />

at 35 y if previous<br />

exam<strong>in</strong>ations have been normal.<br />

Consider cessation at 55 y.<br />

4. If attenuated FAP is suspected,<br />

colonoscopy is advised. Depend<strong>in</strong>g<br />

on the family history this may<br />

beg<strong>in</strong> as late as 18 y and cont<strong>in</strong>ue<br />

beyond 55 y.<br />

5. Gastroduodenoscopy to detect<br />

duodenal adenomas at 1- to 3yearly<br />

<strong>in</strong>tervals from 30 to 35 y is<br />

commonly advised, as most<br />

advanced duodenal adenomas<br />

develop after the age of 40 years.<br />

The Spigelman Criteria may be<br />

used to guide surveillance <strong>in</strong>terval.<br />

Recommendations all grade 3<br />

except for 5. (grade 5)<br />

Hereditary Non-Polyposis<br />

Colon Cancer (HNPCC)<br />

1. Offer referral to a genetic<br />

service for consideration of<br />

genetic test<strong>in</strong>g, <strong>with</strong><strong>in</strong> the<br />

context of appropriate<br />

counsell<strong>in</strong>g, to all at-risk<br />

members of families <strong>with</strong><br />

HNPCC, at the age when<br />

colonoscopic surveillance<br />

would normally beg<strong>in</strong>.<br />

2. For bowel surveillance<br />

colonoscopy is<br />

recommended 2-yearly from<br />

the age of 25 years (or from<br />

an age 5 years before the<br />

earliest age at which CRC<br />

was diagnosed <strong>in</strong> the family,<br />

whichever comes first).<br />

Consider annual<br />

colonoscopy <strong>in</strong> known<br />

mutation carriers.<br />

3. Endometrial cancer is the<br />

most common extracolonic<br />

malignancy. Surveillance <strong>with</strong><br />

annual transvag<strong>in</strong>al<br />

ultrasound (+/- endometrial<br />

aspiration biopsy) is usually<br />

advised for known mutation<br />

carriers and at-risk members<br />

of families <strong>with</strong> HNPCC as<br />

determ<strong>in</strong>ed by the<br />

Amsterdam Criteria if there<br />

is a family history of uter<strong>in</strong>e<br />

cancer and/or genetic test<strong>in</strong>g<br />

is non<strong>in</strong>formative<br />

The efficacy of these<br />

surveillance tools rema<strong>in</strong>s<br />

uncerta<strong>in</strong> <strong>in</strong> premenopausal<br />

younger women.<br />

Recommendations all grade<br />

5, except for 2. (grade 3)<br />

Personal history of CRC<br />

resection<br />

1. Follow-up after resection<br />

of CRC <strong>with</strong> curative <strong>in</strong>tent<br />

is recommended as it allows<br />

practitioners to monitor<br />

treatment outcome and is<br />

consistent <strong>with</strong> the<br />

preference of <strong>in</strong>dividuals<br />

<strong>with</strong> CRC.<br />

2. All such <strong>in</strong>dividuals should<br />

have specialist follow-up<br />

over the time period <strong>in</strong><br />

which the majority of<br />

recurrences (local or<br />

metastatic) are most likely<br />

to occur (3-5 years).<br />

Follow-up should be<br />

appropriate to the cl<strong>in</strong>ical<br />

context. In decid<strong>in</strong>g on<br />

<strong>in</strong>tensity and duration of<br />

follow-up, age and comorbid<br />

conditions should be<br />

considered.<br />

Follow-up should occur <strong>in</strong><br />

conjunction <strong>with</strong>, and<br />

subsequently be cont<strong>in</strong>ued<br />

by, the <strong>in</strong>dividuals general<br />

practitioner.<br />

3. Individuals free of<br />

recurrent CRC for 3 to 5<br />

years should be entered <strong>in</strong>to<br />

a colonoscopy surveillance<br />

program.<br />

Colonoscopy should be<br />

performed at 3- to 5-yearly<br />

<strong>in</strong>tervals.<br />

4. All <strong>in</strong>dividuals <strong>with</strong> CRC<br />

should be <strong>in</strong>formed of the<br />

uncerta<strong>in</strong> efficacy of followup<br />

<strong>with</strong> regard to survival<br />

benefit.<br />

All recommendations grade<br />

5<br />

Personal history of<br />

colonpolyps<br />

1. Adenoma size > 10<br />

mm: colonoscopy<br />

after 3 years - if<br />

negative subsequent<br />

colonoscopy after 3-<br />

5 y<br />

2. > 3 adenomas:<br />

Colonoscopy after 3<br />

years - if negative<br />

subsequent<br />

colonoscopy after 3-<br />

5 y<br />

3. Villous lesions<br />

and/or severe<br />

dysplasia:<br />

Colonoscopy after 3<br />

years - if negative<br />

subsequent<br />

colonoscopy after 3-<br />

5 y<br />

4. Adenomas <strong>with</strong> no<br />

high-risk features and<br />

significant family<br />

history of CRC:<br />

colonoscopy after 3 y<br />

5. Adenomas <strong>with</strong> no<br />

high-risk features and<br />

no family history of<br />

CRC: colonoscopy<br />

after 5-6 y; consider<br />

discont<strong>in</strong>u<strong>in</strong>g<br />

surveillance if<br />

subsequent<br />

surveillance<br />

colonoscopy normal.<br />

All recommendations<br />

grade 3<br />

Inflammatory bowel disease<br />

(IBD)<br />

1. After 8 to 10 years, <strong>in</strong>dividuals<br />

<strong>with</strong> ulcerative colitis (UC)<br />

should undergo colonoscopy<br />

<strong>with</strong> serial biopsies (as detailed<br />

below) to def<strong>in</strong>e disease extent,<br />

both macroscopic and<br />

microscopic. All those <strong>with</strong><br />

significant disease extend<strong>in</strong>g<br />

proximal to the sigmoid colon<br />

should be enrolled <strong>in</strong> a<br />

surveillance program.<br />

2. Colonoscopy is recommended<br />

2-yearly for <strong>in</strong>dividuals <strong>with</strong> UC<br />

after 10 years' disease duration.<br />

At colonoscopy, 2 to 3 biopsies<br />

should be taken from each of 10<br />

sites (caecum, proximal and<br />

distal ascend<strong>in</strong>g colon, proximal<br />

and distal transverse colon,<br />

proximal and distal descend<strong>in</strong>g<br />

colon, proximal and distal<br />

sigmoid colon, and rectum).<br />

Additional biopsies should be<br />

taken from any mass lesions, but<br />

not from pseudopolyps.<br />

3. If high-grade dysplasia (HGD)<br />

is present on biopsy (and<br />

confirmed on histological<br />

review), the <strong>in</strong>dividual should be<br />

referred for colectomy. If lowgrade<br />

dysplasia (LGD) is found <strong>in</strong><br />

the absence of significant<br />

<strong>in</strong>flammation, shorten the<br />

surveillance <strong>in</strong>terval to 1 year<br />

and refer for surgery<br />

4. All <strong>in</strong>dividuals <strong>with</strong> extensive<br />

colorectal Crohn s disease<br />

should undergo surveillance<br />

procedures as detailed for<br />

<strong>in</strong>dividuals <strong>with</strong> extensive UC.<br />

Recommendations grade 3, for<br />

Crohn s disease grade 4<br />

Miscellaneous<br />

1. Individuals <strong>with</strong><br />

hamartomatous polyps<br />

of the large or small<br />

bowel, or those <strong>with</strong> a<br />

first-degree relative<br />

known to have multiple<br />

polyps alone or<br />

associated <strong>with</strong> CRC,<br />

should be referred to<br />

the appropriate bowel<br />

and genetic specialists.<br />

2. Individuals identified<br />

to have hyperplastic<br />

polyps beyond the<br />

rectosigmoid junction<br />

<strong>with</strong> risk features<br />

should be referred to<br />

the appropriate bowel<br />

and genetic specialists.<br />

Risk features <strong>in</strong>clude:<br />

Unusual numbers (><br />

20)<br />

Unusual size (> 10<br />

mm)<br />

Location <strong>in</strong> the<br />

proximal colon<br />

Presence of highgrade<br />

dysplasia<br />

Co<strong>in</strong>cidental<br />

adenomas<br />

A first-degree relative<br />

<strong>with</strong> high-risk<br />

hyperplastic polyps<br />

A first-degree relative<br />

<strong>with</strong> CRC<br />

Recommendations all<br />

grade 5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!